High expression of R3HDM1 was identified as a risk factor for the occurrence and progression of tumors, particularly in six types of cancers (ACC, LUAD, MESO, UCEC, THCA, and KIRP). This evidence concerns the gene R3HDM1 and adrenal cortex carcinoma.